FDA Inspection 1043275 — AGC Biologics A/S

AGC Biologics A/S — FEI 3004708748

The FDA completed an inspection of AGC Biologics A/S on Nov 7, 2017 in Soborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 7, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Soborg (Denmark)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.